DENG Yan, Shirlly


Current Position:
Research Associate


Office Phone:
(852) 2352 1798



1The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer
Chen J, Deng Y, Ao L, Song Y, Xu Y, Wang CC, Choy KW, Chung TKH, Du Q, Sui Y, Yang T, Yang J, Li H, Zou C, Tang T
Cancer Lett. 2019 Sep 24;460:75-85
2Local Administration of siRNA through Microneedle: Optimization, Bio-distribution, Tumor Suppression and Toxicity.
Tang T, Deng Y, Chen J, Zhao Y, Yue RF, Choy KW, Wang CC, Du Q, Xu Y, Han L, Chung TKH
Sci Rep 2016;6 30(430): 1 - 8
3Transdermal Delivery of siRNA through Microneedle Array.
Deng Y, Chen J, Zhao Yi, Yan X, Zhang L, Choy KW, Hu J, Sant HJ, Gale BK, Tang T
Sci Rep 2016;621(422): 1 - 8
4Magnetite Nanostructured Porous Hollow Helical Microswimmers for Targeted Delivery.
Yan X, Zhou Q, Yu J, Xu T, Deng Y, Tang T, Feng Q, Bian L, Zhang Y, Ferreira A, Zhang L
Adv Funct Mater 2015;25(33): 5333 - 5342
5Nanocomposite-strengthened Dissolving Microneedles for Improved Transdermal Delivery to Human Skin.
Yan L, Raphael AP, Zhu X, Wang B, Chen W, Tang T, Deng Y, Sant HJ, Zhu G, Choy KW, Gale BK, Prow TW, Chen X
Adv Healthc Mater 2014;3(4): 555 - 564
6Therapeutic Potentials of Gene Silencing by RNA Interference: Principles, Challenges, and New Strategies.
Deng Y, Wang CC, Choy KW, Du Q, Chen J, Wang Q, Li L, Chung TKH, Tang T
Gene 2014;538: 217 - 227